Physician profile
Jodi Williams
NPI 1669977062
$1,108.63
in general payments reported to CMS, 2019-2025
12 companies · $529 in 2025
The $529 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.55 · 2023: $132 · 2024: $372 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.58 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $157.54 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Sequel Med Tech, LLC | $155.61 | 2025 | Twiist |
| Lilly USA, LLC | $132.03 | 2023 | Mounjaro |
| Sanofi-Aventis U.S. LLC | $125.00 | 2024 | |
| Tandem Diabetes Care, INC. | $121.84 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $111.88 | 2024 | Ilet Bionic Pancreas |
| Cequr Corporation | $110.91 | 2024 | Cequr Simplicity |
| Abbvie INC. | $56.32 | 2021 | |
| Medline Industries LP | $51.87 | 2025 | |
| Mannkind Corporation | $42.50 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $23.90 | 2024 | Andexxa |
| Genentech USA, INC. | $19.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.